Rocket Pharmaceuticals (RCKT) Total Debt (2014)

Rocket Pharmaceuticals (RCKT) posted Total Debt of $2.6 million for Q4 2014.

Rocket Pharmaceuticals (RCKT) Total Debt (2014) Analysis & Trends

Rocket Pharmaceuticals has reported Total Debt for 1 years, with the latest figure at $2.6 million in Q4 2014.

Quarterly Total Debt changed N/A year-over-year to $2.6 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $2.6 million (changed N/A YoY) and the FY2014 annual result came in at $2.6 million, changed N/A from the prior year.
Total Debt steadied at $2.6 million in Q4 2014 per RCKT's latest filing.
Over five years, Total Debt peaked at $2.6 million in Q4 2014 and troughed at $2.6 million in Q4 2014.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	1.99 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	1.07 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	9.34 Bn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	546.77 Mn
10	Rocket Pharmaceuticals	380.92 Mn	380.92 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2014	2.55 Mn